The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Amiodarone pulmonary toxicity - Amiodarone lung
See under PMID 15062598 (review), 29631763 (Pathology) and Camus, Ph., T.V. Colby, E.C.I. Rosenow, Amiodarone pulmonary toxicity. In Drug-induced and iatrogenic lung disease. P. Camus and E.C. Rosenow, Editors. 2010, Hodder Arnold: London UK
Publications
Iatrogenic pulmonary lesions.
Seminars in diagnostic pathology 2018 Jul;35;260-271 — 2018 Jul — 260-271
Amiodarone pulmonary toxicity.
Clinics in chest medicine 2004 Mar;25;65-75 — 2004 Mar — 65-75
Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry.
Annals of diagnostic pathology 1997 Oct;1;47-56 — 1997 Oct — 47-56
[Interstitial pneumopathy in subjects treated with amiodarone].
Presse medicale (Paris, France : 1983) 1983 Nov 26;12;2747-50 — 1983 Nov 26 — 2747-50
Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases.
American journal of clinical pathology 1987 Jan;87;7-13 — 1987 Jan — 7-13
Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2).
Chest 1988 Jun;93;1242-8 — 1988 Jun — 1242-8
Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).
Chest 1988 May;93;1067-75 — 1988 May — 1067-75